Please login to the form below
Artificial Intelligence: the new healthcare algorithm
The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare. Associate Medical Copywriter Kulveer Singh dives deeper into the technology.
Artificial Intelligence (AI) is
the science
and engineering of making intelligent machines, and the art of using
computers to understand human intelligence. When it comes to healthcare, AI can
bring about radical changes to the way doctors and physicians access,
communicate, and interact with patient data. Crucially, this can result in
improved patient outcomes and even the possibility of using an individual
patient’s history - such as previous illnesses, allergies or even genetic
makeup - to predict their
exact treatment requirements.
Associate Medical Copywriter Kulveer Singh explains how the introduction of AI can change the landscape of healthcare, why it’s an exciting time for the development of new technologies, and the challenges that implementing new AI may pose.
With its ability to use natural language capabilities, hypothesis generation, and evidence-based learning, IBM WATSON has made the switch to healthcare and can support physicians in key decision-making processes. For example, an oncologist can use WATSON to assist in diagnosing and treating cancer patients. First, they might pose a query to the system, describing symptoms and other related factors (e.g. a patient has been suffering from severe and unexplained tiredness). WATSON begins by identifying the key pieces of information before mining through patient-related data to find relevant facts about family history, current medications, and other existing conditions. It combines this information with current findings from oncology clinical tests, doctors’ notes, treatment guidelines, instrument data, and scientific literature. It then examines these sources before forming hypotheses and testing them. WATSON will then provide a list of possible diagnoses with an accompanying score that indicates the level of confidence for each hypothesis. This contextual analysis allows WATSON to address complex problems, helping the doctor make more informed and accurate decisions.
Even Google with their DeepMind Health AI technology, have entered into the first NHS research project investigating how machine learning can help analyse ophthalmic scans, leading to earlier detection and intervention for patients with macular deterioration.
![]()
Associate Medical Copywriter Kulveer Singh explains how the introduction of AI can change the landscape of healthcare, why it’s an exciting time for the development of new technologies, and the challenges that implementing new AI may pose.
Better than humans? There’s proof!
In 2011, IBM’s supercomputer WATSON competed against and obliterated a long-term game show champion. All this, despite the general thought that computer programmes were unable to understand natural language, puns, red herrings, and to simply unpack the meaning behind game show questions.With its ability to use natural language capabilities, hypothesis generation, and evidence-based learning, IBM WATSON has made the switch to healthcare and can support physicians in key decision-making processes. For example, an oncologist can use WATSON to assist in diagnosing and treating cancer patients. First, they might pose a query to the system, describing symptoms and other related factors (e.g. a patient has been suffering from severe and unexplained tiredness). WATSON begins by identifying the key pieces of information before mining through patient-related data to find relevant facts about family history, current medications, and other existing conditions. It combines this information with current findings from oncology clinical tests, doctors’ notes, treatment guidelines, instrument data, and scientific literature. It then examines these sources before forming hypotheses and testing them. WATSON will then provide a list of possible diagnoses with an accompanying score that indicates the level of confidence for each hypothesis. This contextual analysis allows WATSON to address complex problems, helping the doctor make more informed and accurate decisions.
Even Google with their DeepMind Health AI technology, have entered into the first NHS research project investigating how machine learning can help analyse ophthalmic scans, leading to earlier detection and intervention for patients with macular deterioration.
Download the full article from Blue Latitude Health
Company Details
Blue Latitude Health
+44 203 328 1840
Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom
Latest content on this profile
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance treatment and improve patient and stakeholder outcomes.
Blue Latitude Health
- The changing face of pharma in the precision era
- Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.
Blue Latitude Health
- Creative problem solving, solved
- Customer Experience Consultant Eimear Power explains how pharma teams can unlock their creativity and foster truly innovative ideas.
Blue Latitude Health
- Three strategies for managing loss of exclusivity successfully
- Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.
Blue Latitude Health
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.
Blue Latitude Health
